Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 223-231

  Liang, Chao Fan ^a   Au, Alice Lai Shan ^b   Leung, Susan Wai Sum ^a   Ng, Kwok Fu Jacobus ^a   Félétou, Michel ^c   Kwan, Yiu Wa ^b   Man, Ricky Ying Keung ^a   Vanhoutte, Paul M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; ENDOTHELIN 1; GLIBENCLAMIDE; IBERIOTOXIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DESENSITIZATION; ISOMETRICS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CORONARY VESSELS; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUANYLATE CYCLASE; ION CHANNEL GATING; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDES; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; OXAZINES; PATCH-CLAMP TECHNIQUES; PEPTIDES; SWINE; VASODILATION;

EID: 77953804779     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.166652     Document Type: Article

References (40)

1. Amin J, Carretero OA, and Ito S (1996) Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide. Hypertension 27:684-687. (Pubitemid 26086233)
2. Barber DA, Burnett JC Jr, Fitzpatrick LA, Sieck GC, and Miller VM (1998) Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries. J Cardiovasc Pharmacol 32:5-11.
3. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, and Cohen RA (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853.
4. Chauhan SD, Hobbs AJ, and Ahluwalia A (2004) C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor. Int J Biochem Cell Biol 36:1878-1881.
5. Cox DH (2005) The BKCa channel's Ca2+-binding sites, multiple sites, multiple ions. J Gen Physiol 125:253-255.
6. Edwards G, Niederste-Hollenberg A, Schneider J, Noack T, and Weston AH (1994) Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br J Pharmacol 113:1538-1547. (Pubitemid 24364445)
7. Ehlert FJ, Ostrom RS, and Sawyer GW (1997) Subtypes of the muscarinic receptor in smooth muscle. Life Sci 61:1729-1740.
8. Félétou M and Vanhoutte PM (2006) Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 26:1215-1225.
9. Friebe A and Koesling D (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93:96-105.
10. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, and Schenk DB (1988) Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 263:9395-9401.
11. Hedayati N, Annambhotla S, Jiang J, Wang X, Chai H, Lin PH, Yao Q, and Chen C (2009) Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg 49:199-207.
12. Ignarro LJ, Byrns RE, Buga GM, and Wood KS (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61:866-879.
13. Kediia G, Uckert S, Kediia M, Truss MC, Chigogidze T, Jonas U, and Managadze LG (2006) [In vitro effects of cAMP- and cGMP-stimulating drugs on the relaxation of the prostate smooth muscle tissue contraction induced by endothelin-1]. Georgian Med News 131:7-13.
14. Keung W, Vanhoutte PM, and Man RY (2005) Nongenomic responses to 17β-estradiol in male rat mesenteric arteries abolish intrinsic gender differences in vascular responses. Br J Pharmacol 146:1148-1155.
15. Ko EA, Han J, Jung ID, and Park WS (2008) Physiological roles of K+ channels in vascular smooth muscle cells. J Smooth Muscle Res 44:65-81.
16. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, and Goeddel DV (1991) Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252:120-123. (Pubitemid 21916951)
17. Leuranguer V, Vanhoutte PM, Verbeuren T, and Félétou M (2008) C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br J Pharmacol 153:57-65.
18. Levin ER, Gardner DG, and Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328.
19. Lüscher TF and Vanhoutte PM (1986) Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344-348. (Pubitemid 16042204)
20. Madhani M, Scotland RS, MacAllister RJ, and Hobbs AJ (2003) Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139:1289-1296.
21. Mistry DK and Garland CJ (1998) Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124:1131-1140.
22. Miyoshi H and Nakaya Y (1994) Endotoxin-induced nonendothelial nitric oxide activates the Ca(2+)-activated K+ channel in cultured vascular smooth muscle cells. J Mol Cell Cardiol 26:1487-1495.
23. Moncada S and Vane JR (1978) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30:293-331.
24. Moncada S, Palmer RM, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
25. Ndiaye M, Chataigneau T, Andriantsitohaina R, Stoclet JC, and Schini-Kerth VB (2003) Red wine polyphenols cause endothelium-dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. Biochem Biophys Res Commun 310:371-377.
26. O'Rourke ST, Hammad H, Delagrange P, Scalbert E, and Vanhoutte PM (2003) Melatonin inhibits nitrate tolerance in isolated coronary arteries. Br J Pharmacol 139:1326-1332.
27. Palmer RM, Ferrige AG, and Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
28. Peral de Bruno M, Romano L, Proto M, and Coviello A (1999) Atrial natriuretic peptide relaxes arterial basal tone induced by coarctation hypertension. Peptides 20:485-491.
29. Robertson BE, Schubert R, Hescheler J, and Nelson MT (1993) cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol 265:C299-C303.
30. Rubanyi G and Vanhoutte PM (1985) Endothelium removal decreases relaxations canine coronary arteries caused by β-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 7:139-144. (Pubitemid 15162256)
31. Sandow SL and Tare M (2007) C-type natriuretic peptide: a new endothelium-derived hyperpolarizing factor? Trends Pharmacol Sci 28:61-67.
32. Seto SW, Au AL, Lam TY, Chim SS, Lee SM, Wan S, Tjiu DC, Shigemura N, Yim AP, Chan SW, et al. (2007) Modulation by simvastatin of iberiotoxin-sensitive, Ca2+-activated K+ channels of porcine coronary artery smooth muscle cells. Br J Pharmacol 151:987-997.
33. Shan Au AL, Kwan YW, Kwok CC, Zhang RZ, and He GW (2003) Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery. Eur J Pharmacol 468:199-207.
34. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, and Burnett JC Jr (1992) Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol Heart Circ Physiol 263:H1318-H1321.
35. Tang EH, Feletou M, Huang Y, Man RY, and Vanhoutte PM (2005) Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractions. Am J Physiol Heart Circ Physiol 289:H2434-H2440.
36. Tang EH, Jensen BL, Skott O, Leung GP, Feletou M, Man RY, and Vanhoutte PM (2008) The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res 78:130-138.
37. Vanhoutte PM and Tang EH (2008) Endothelium-dependent contractions: when a good guy turns bad! J Physiol 586:5295-5304.
38. Woodard GE and Rosado JA (2008) Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 268:59-93.
39. Wright RS, Wei CM, Kim CH, Kinoshita M, Matsuda Y, Aarhus LL, Burnett JC Jr, and Miller WL (1996) C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems. J Am Coll Cardiol 28:1031-1038.
40. Yang D, Gluais P, Zhang JN, Vanhoutte PM, and Félétou M (2004) Nitric oxide and inactivation of the endothelium-dependent contracting factor released by acetylcholine in spontaneously hypertensive rat. J Cardiovasc Pharmacol 43:815-820.